In newly diagnosed type 2 diabetic patients had insulin and C-peptid levels that were higher than control group with statistical significance (p <0.001), insulin resistance increased 93.62% and 98.7%; beta cell function reduced 51.91% and 57.52%, insulin sesitivity decreased 36.32% and 44.79%; insulin resistance and beta cell function reducing patient rate 68.3%, 76.9% and 84.7% 82.2% for calculating insulin and C-peptid.